Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
12
KROS
Keros Therapeutics
Last Price:
$16.52
Seasonality Move:
5.39%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.39 | Sell |
20-day SMA: | 40.81 | Sell |
50-day SMA: | 52.4 | Sell |
200-day SMA: | 53.08 | Sell |
8-day EMA: | 21.09 | Sell |
20-day EMA: | 34.05 | Sell |
50-day EMA: | 46.12 | Sell |
200-day EMA: | 50.87 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.99 | Sell |
Relative Strength Index (14 RSI): | 22.72 | Sell |
Chaikin Money Flow: | 728924 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22 - 65.52) | Sell |
Bollinger Bands (100): | (39.17 - 65.75) | Sell |
Keros Therapeutics Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.81 while KROS 8-day simple moving average is 17.39, which is a Sell signal.
-
The stock price of KROS is 16.81 while Keros Therapeutics 20-day SMA is 40.81, which makes it a Sell.
-
Keros Therapeutics 50-day simple moving average is 52.40 while KROS share price is 16.81, making it a Sell technically.
-
KROS stock price is 16.81 and Keros Therapeutics 200-day simple moving average is 53.08, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
12
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $16.81. The Score for KROS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
680.9M
Price in USD:
16.81
Share Volume:
997.3K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
15.67
Sell
12
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 16.81 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 16.81 while KROS 8-day exponential moving average is 21.09, which is a Sell signal.
-
The stock price of KROS is 16.81 while Keros Therapeutics 20-day EMA is 34.05, which makes it a Sell.
-
Keros Therapeutics 50-day exponential moving average is 46.12 while KROS share price is 16.81, making it a Sell technically.
-
KROS stock price is 16.81 and Keros Therapeutics 200-day simple moving average is 50.87, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $0.36 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -11.99, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 22.72, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is (22 - 65.52), which suggest Keros Therapeutics is a Sell
-
The Bollinger Bands (100) for Keros Therapeutics is (39.17 - 65.75), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.